Evolution of Psychosis in Youth: Multimodal Risk and Resilience Markers

青年精神病的演变:多模式风险和弹性标记

基本信息

  • 批准号:
    10401818
  • 负责人:
  • 金额:
    $ 72.62万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-07-15 至 2024-04-30
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY Efforts at early identification of individuals at risk for psychosis are propelled by the realization that psychosis is neurodevelopmental, with brain and behavioral abnormalities anteceding diagnosis of schizophrenia (SZ) by years. As longer duration of untreated psychosis portends poor outcome, early identification is important to bend the developmental trajectory in a favorable direction. Since most current studies of psychosis risk are based on help-seeking samples, there is a gap in knowledge on how psychosis unfolds in diverse community samples. While it is generally recognized that genomic and environmental factors (GxE) contribute to risk for psychosis, there is a paucity of complementary integrative studies that can chart causal pathways. Genomic “case-control” GWAS studies of SZ identified multiple common alleles permitting calculation of a polygenic risk score (PRS). Recently, increased attention has been given to childhood adversity related to SZ. The goal of the proposed R01 is to build on our genotyped ~10,000 Philadelphia Neurodevelopmental Cohort (PNC) of 8 to 21 years old youths studied in 2009-2011, where we are following those who meet criteria or are at risk for psychosis (PS) and typically developing (TD) participants, whose current age range is 15-30 years. Available multi-level “deep phenotyping” includes clinical, neurocognition and multi-modal neuroimaging on a subsample of ~1600. We have developed a preliminary environmental risk score (ERS) and will use it to dissect GxE. The proposed followup design will recruit PS and TD participants with the highest and lowest scorers (quartile) on the ERS, and within each of these four cells we will examine 120 individuals, 60 males and 60 females (total N=480). This sample will be examined clinically, neurocognitively and with multimodal neuroimaging. We will test the hypothesis that genomic vulnerabilities, based on PRS and family history, and environmental adversity, based on ERS, updated longitudinally, affect onset and course of PS by altering brain development in temporolimbic regions affecting fronto-limbic connectivity that underlies social functioning. We will augment current data with information on risk and resilience and multimodal brain-behavior parameters to establish developmental trajectories during this critical period of brain maturation when psychosis emerges. Our aims are: 1. Examine effects of ERS on PS clinical features and progression in relation to PRS. 2. Investigate brain- behavior parameters that bridge from genetic and environmental factors to clinical manifestations. 3. Establish developmental trajectories for PS features, associated brain parameters and neurocognitive deficits, and apply novel computational models to enable an adaptive “risk and resilience calculator”. The proposed study will produce the data absent for a diverse US community sample but needed to move psychiatry into the precision medicine era. The project will inform on genomic and environmental risk and resilience indicators, offering an essential rung in the ladder toward individualized prediction, a part of implementation science. As with the PNC, data and associated algorithms will be a resource shared with the scientific community.
项目概要 认识到精神病是一种疾病,从而推动早期识别有精神病风险的个体。 神经发育,在诊断精神分裂症(SZ)之前存在大脑和行为异常 年。由于未经治疗的精神病持续时间较长预示着结果不佳,因此早期识别对于 使发展轨迹向有利的方向发展。由于目前大多数关于精神病风险的研究都是 根据寻求帮助的样本,对于精神病在不同社区中如何发展存在知识差距 样品。虽然人们普遍认为基因组和环境因素 (GxE) 会导致风险 精神病方面,缺乏可以绘制因果路径的补充性综合研究。基因组 SZ 的“病例对照”GWAS 研究确定了多个常见等位基因,可以计算多基因风险 分数(PRS)。最近,与 SZ 相关的儿童逆境受到越来越多的关注。目标是 拟议的 R01 是建立在我们基因分型的约 10,000 个费城神经发育队列 (PNC) 的基础上,其中 8 至 2009-2011 年研究的 21 岁青少年,我们正在跟踪那些符合标准或有风险的人 精神病 (PS) 和典型发育 (TD) 参与者,目前年龄范围为 15-30 岁。可用的 多层次“深度表型分析”包括子样本的临床、神经认知和多模式神经影像 约 1600。我们已经制定了初步的环境风险评分 (ERS),并将用它来剖析 GxE。这 拟议的后续设计将招募具有最高和最低得分者(四分位数)的 PS 和 TD 参与者 ERS,在这四个单元中的每一个单元中,我们将检查 120 个人,其中 60 名男性和 60 名女性(总共 N=480)。该样本将通过临床、神经认知和多模式神经影像检查。我们将 检验基于 PRS 和家族史以及环境逆境的基因组脆弱性的假设, 基于 ERS,纵向更新,通过改变大脑发育来影响 PS 的发生和过程 颞边缘区域影响作为社会功能基础的额边缘连接。我们将增强 当前数据包含有关风险和复原力的信息以及多模式大脑行为参数,以建立 当精神病出现时,大脑成熟的关键时期的发育轨迹。我们的目标 包括: 1. 检查 ERS ​​对 PS 临床特征和与 PRS 相关的进展的影响。 2. 研究大脑- 将遗传和环境因素与临床表现联系起来的行为参数。 3. 建立 PS 特征、相关大脑参数和神经认知缺陷的发育轨迹,并应用 新颖的计算模型可实现自适应“风险和弹性计算器”。拟议的研究将 产生美国不同社区样本所缺少的数据,但需要将精神病学推向精确 医学时代。该项目将提供有关基因组和环境风险及复原力指标的信息,提供 个性化预测是实现科学的一部分的重要一步。与 PNC、数据和相关算法将成为与科学界共享的资源。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Raquel E Gur其他文献

Olfactory Dysfunction in Schizophrenia: A Qualitative and Quantitative Review
精神分裂症中的嗅觉障碍:定性和定量综述
  • DOI:
    10.1016/s0893-133x(99)00019-6
  • 发表时间:
    1999-09-01
  • 期刊:
  • 影响因子:
    7.100
  • 作者:
    Paul J Moberg;Rachel Agrin;Raquel E Gur;Ruben C Gur;Bruce I Turetsky;Richard L Doty
  • 通讯作者:
    Richard L Doty
span style=font-family:;font-size:12pt;Happy facial expression processing with different social interaction cues: An fMRI study of individuals with schizotypal personality traits/span
不同社交互动线索下的快乐面部表情处理:对具有精神分裂型人格特征的个体的功能磁共振成像研究
Neuropsychological Vulnerability Markers of Schizophrenia
精神分裂症的神经心理学易损性标志物
  • DOI:
    10.1038/sj.npp.1380145
  • 发表时间:
    2003-07-25
  • 期刊:
  • 影响因子:
    7.100
  • 作者:
    Lisa T Eyler Zorrilla;Tyrone D Cannon;Raquel E Gur;Ruben C Gur
  • 通讯作者:
    Ruben C Gur

Raquel E Gur的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Raquel E Gur', 18)}}的其他基金

1/9: Dissecting the effects of genomic variants on nenriched for neuropsychiatric disorderseurobehavioral dimensions in CNVs
1/9:剖析基因组变异对 CNV 神经精神疾病神经行为维度富集的影响
  • 批准号:
    10088064
  • 财政年份:
    2019
  • 资助金额:
    $ 72.62万
  • 项目类别:
Evolution of Psychosis in Youth: Multimodal Risk and Resilience Markers
青年精神病的演变:多模式风险和弹性标记
  • 批准号:
    10612018
  • 财政年份:
    2019
  • 资助金额:
    $ 72.62万
  • 项目类别:
1/9: Dissecting the effects of genomic variants on nenriched for neuropsychiatric disorderseurobehavioral dimensions in CNVs
1/9:剖析基因组变异对 CNV 神经精神疾病神经行为维度富集的影响
  • 批准号:
    10597092
  • 财政年份:
    2019
  • 资助金额:
    $ 72.62万
  • 项目类别:
1/9: Dissecting the effects of genomic variants on nenriched for neuropsychiatric disorderseurobehavioral dimensions in CNVs
1/9:剖析基因组变异对 CNV 神经精神疾病神经行为维度富集的影响
  • 批准号:
    10402282
  • 财政年份:
    2019
  • 资助金额:
    $ 72.62万
  • 项目类别:
Evolution of Psychosis in Youth: Multimodal Risk and Resilience Markers
青年精神病的演变:多模式风险和弹性标记
  • 批准号:
    9978131
  • 财政年份:
    2019
  • 资助金额:
    $ 72.62万
  • 项目类别:
1/9: Dissecting the effects of genomic variants on nenriched for neuropsychiatric disorderseurobehavioral dimensions in CNVs
1/9:剖析基因组变异对 CNV 神经精神疾病神经行为维度富集的影响
  • 批准号:
    9761630
  • 财政年份:
    2019
  • 资助金额:
    $ 72.62万
  • 项目类别:
Schizophrenia: A Neuropsychiatric Perspective
精神分裂症:神经精神病学的视角
  • 批准号:
    9392422
  • 财政年份:
    2016
  • 资助金额:
    $ 72.62万
  • 项目类别:
3/3: Pedigree-Based Whole Genome Sequencing of Affective and Psychotic Disorders
3/3:基于谱系的情感和精神障碍全基因组测序
  • 批准号:
    8806281
  • 财政年份:
    2015
  • 资助金额:
    $ 72.62万
  • 项目类别:
3/3: Pedigree-Based Whole Genome Sequencing of Affective and Psychotic Disorders
3/3:基于谱系的情感和精神障碍全基因组测序
  • 批准号:
    9232211
  • 财政年份:
    2015
  • 资助金额:
    $ 72.62万
  • 项目类别:
Development Trajectories of Negative Symptoms in Schizophrenia
精神分裂症阴性症状的发展轨迹
  • 批准号:
    8887151
  • 财政年份:
    2014
  • 资助金额:
    $ 72.62万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 72.62万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 72.62万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 72.62万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 72.62万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 72.62万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 72.62万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 72.62万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 72.62万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 72.62万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 72.62万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了